Related Experiment Video

Updated: Jun 11, 2026

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells
09:27

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells

Published on: April 2, 2021

Synergy of caspofungin with human polymorphonuclear granulocytes for killing Candida albicans

Vivian Tullio1, Narcisa Mandras, Daniela Scalas

  • 1Department of Public Health and Microbiology, Microbiology Section, University of Turin, Via Santena 9, 10126 Turin, Italy. vivian.tullio@unito.it

Antimicrobial Agents and Chemotherapy
|June 30, 2010
PubMed

Insights

Caspofungin enhances the immune system's ability to kill Candida albicans by boosting polymorphonuclear leukocyte (PMN) activity. This antifungal drug shows promise for treating invasive fungal infections, even those resistant to other treatments.

Area of Science:

  • Mycology
  • Immunology
  • Pharmacology

Background:

  • Invasive fungal infections, particularly those caused by Candida albicans, pose a significant threat, especially in immunocompromised patients.
  • Conventional antifungal therapies like azoles can be associated with resistance and treatment failures.
  • Polymorphonuclear leukocytes (PMNs) are crucial phagocytic cells in the innate immune response against fungal pathogens.

Purpose of the Study:

  • To investigate the effect of caspofungin on the phagocytic and intracellular killing capabilities of PMNs against Candida albicans.
  • To determine if caspofungin can enhance the host immune response in combating candidal infections.

Main Methods:

  • In vitro study evaluating the interaction between caspofungin and PMNs.
  • Assessing PMN phagocytosis and intracellular killing of Candida albicans in the presence of varying caspofungin concentrations (2, 3.2, and 8 microg/ml).

Main Results:

  • Caspofungin significantly increased the intracellular killing of Candida albicans by PMNs at all tested concentrations.
  • The drug demonstrated a direct action on both Candida albicans cells and PMNs, enhancing their fungicidal activity.
  • Evidence suggests caspofungin can synergize with phagocytic cells for effective fungal clearance.

Conclusions:

  • Caspofungin enhances PMN-mediated killing of Candida albicans, indicating a potential immunomodulatory role.
  • This synergistic action suggests caspofungin could be a valuable therapeutic agent for invasive candidiasis.
  • Caspofungin may offer an effective treatment option for invasive fungal infections refractory to azole therapy.

More Related Videos

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis09:44

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis

Published on: June 13, 2021

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...